coronavirus
cov
positivestrand
rna
virus
genom
size
approxim
kb
close
relat
member
torovirina
form
second
subfamili
famili
coronavirida
togeth
three
famili
arterivirida
mesonivirida
ronivirida
coronavirida
part
order
nidoviral
coronavirida
divid
four
genera
alphacoronaviru
betacoronaviru
gammacoronaviru
deltacoronaviru
felin
coronavirus
fcov
close
relat
canin
coronavirus
ccov
porcin
transmiss
gastroenter
viru
tgev
three
classifi
one
viru
speci
call
alphacoronaviru
distantli
relat
virus
genu
alphacoronaviru
includ
exampl
porcin
epidem
diarrhea
viru
pedv
human
coronaviru
human
coronaviru
fcov
widespread
among
cat
seroposit
rate
domest
cat
popul
multicat
household
anim
shelter
basi
antigen
properti
fcov
classifi
two
serotyp
vast
major
natur
infect
occur
worldwid
caus
serotyp
fcov
serotyp
ii
fcov
less
common
field
mainli
occur
asia
interestingli
serotyp
ii
fcov
evolv
recombin
serotyp
fcov
ccov
fcov
serotyp
two
biotyp
fundament
differ
pathogen
cat
defin
felin
enter
coronaviru
fecv
caus
persist
infect
gut
minor
clinic
symptom
sharp
contrast
felin
infecti
periton
viru
fipv
second
biotyp
caus
fatal
system
diseas
term
felin
infecti
periton
fip
character
fibrin
andor
granulomat
seros
proteinrich
serou
effus
bodi
caviti
granulomat
lesion
variou
organ
gener
accept
harmless
fecv
evolv
highli
pathogen
fipv
accumul
mutat
genom
parent
fecv
result
fipv
cat
refer
viru
pair
date
mutat
respons
fecvfipv
biotyp
switch
identifi
howev
basi
extens
compar
sequenc
analys
fecv
fipv
isol
conclud
mutat
accessori
gene
involv
develop
fip
regard
accessori
gene
attract
particular
interest
found
contain
delet
frameshift
mutat
nonsynonym
mutat
fipv
isol
fecv
carri
intact
gene
accordingli
mutat
consid
import
virul
marker
associ
fip
develop
morerec
public
suggest
intact
gene
requir
viral
replic
gut
contrast
previou
suggest
mutat
necessarili
link
develop
fip
howev
stage
possibl
exclud
mutat
lead
truncat
loss
code
sequenc
contribut
emerg
virus
caus
fip
report
recent
studi
base
compar
sequenc
analys
complet
fecv
fipv
genom
three
substitut
gene
suggest
discrimin
fipv
fecv
two
chang
locat
fusion
peptid
fp
one
heptad
repeat
region
protein
propos
substitut
chang
viral
cell
tropism
enabl
effici
infect
monocytesmacrophag
anoth
studi
concentr
differ
furin
cleavag
site
locat
domain
protein
respect
analys
reveal
fecv
contain
intact
function
furin
cleavag
motif
wherea
fipv
amino
acid
chang
within
close
furin
cleavag
site
therebi
affect
effici
furinmedi
protein
cleavag
modul
furin
cleavag
substitut
respect
motif
propos
import
switch
fecv
fipv
comprehens
compar
sequenc
analys
fecv
fipv
led
identif
mutat
assum
relev
gener
fipv
howev
idea
particular
mutat
fcov
gene
andor
accessori
gene
inde
lead
biotyp
switch
fecv
fipv
remain
experiment
verifi
order
assess
involv
mutat
fipv
develop
gener
welldefin
virus
revers
genet
requir
one
major
obstacl
studi
molecular
pathogenesi
fip
failur
grow
serotyp
field
fecvsfipv
standard
cell
cultur
system
thu
far
revers
genet
system
fecv
field
isol
avail
serotyp
fipv
laboratori
strain
grown
vitro
virus
lost
abil
induc
fip
due
cell
cultur
adapt
although
serotyp
ii
fipv
grown
cell
cultur
also
induc
fip
lack
correspond
serotyp
ii
fecv
limit
use
articl
describ
establish
first
revers
genet
system
serotyp
fecv
field
isol
show
system
overcom
limit
caus
inabl
propag
field
virus
vitro
enabl
effici
recoveri
recombin
serotyp
fecv
cdna
clone
importantli
provid
evid
recov
recombin
fecv
induc
product
infect
natur
host
featur
resembl
natur
infect
caus
virus
studi
aim
establish
revers
genet
system
base
serotyp
fecv
field
isol
start
materi
fecal
sampl
clinic
healthi
cat
longterm
histori
fecv
shed
collect
fulllength
genom
sequenc
determin
sequenc
analys
overlap
revers
transcriptionpcr
rtpcr
fragment
amplifi
viral
rna
deposit
genbank
see
nt
genom
serotyp
fecv
field
isol
typic
genom
organ
fcov
untranscrib
region
fecv
genom
found
compris
nt
respect
downstream
replicas
gene
nt
four
structur
protein
gene
code
spike
protein
nt
envelop
protein
e
nt
membran
protein
nt
nucleoprotein
n
nt
locat
accessori
gene
nt
locat
e
gene
wherea
accessori
gene
locat
downstream
n
gene
nt
vaccinia
virusbas
system
shown
excel
tool
gener
genet
manipul
fulllength
coronaviru
cov
cdna
clone
use
produc
fulllength
genom
rna
follow
transfect
initi
viral
replic
suitabl
cell
gener
viru
titer
obtain
transfect
passag
low
product
hightit
viru
stock
recombin
virus
requir
amplif
step
vitro
accordingli
revers
genet
system
establish
cov
includ
fcov
cell
cultur
system
avail
effici
support
viral
replic
serotyp
fecv
field
isol
propag
standard
cell
cultur
system
address
problem
sought
recov
recombin
fecv
without
vitro
passag
step
first
step
toward
goal
gener
recombin
serotyp
fecv
gene
replac
serotyp
ii
fcov
strain
latter
viru
chosen
gene
donor
previou
experi
demonstr
particular
gene
convey
effici
viral
growth
vitro
use
approach
sought
address
issu
whether
genom
fecv
field
isol
character
studi
support
replic
give
rise
product
infecti
fecv
progeni
engin
chimera
gene
basi
vrecfcovii
contain
fulllength
cdna
serotyp
ii
fcov
strain
construct
recombin
vaccinia
viru
contain
serotyp
ii
fcov
strain
sequenc
backbon
serotyp
field
isolatederiv
cdna
shown
fig
modif
vrecfcovii
carri
multipl
step
vaccinia
virusmedi
homolog
recombin
first
sequenc
downstream
gene
e
n
replac
correspond
part
fecv
field
isol
cdna
result
second
serotyp
iideriv
open
read
frame
sequenc
remov
cdna
serotyp
ii
replac
correspond
fecv
part
thu
result
vaccinia
viru
contain
fecvderiv
e
n
sequenc
gene
serotyp
ii
fcov
strain
final
gener
miss
part
fecv
field
isol
introduc
cdna
construct
sequenc
fulllength
fcov
cdna
insert
vaccinia
viru
genom
verifi
sequenc
analysi
recov
recombin
fecv
serotyp
ii
protein
vaccinia
viru
dna
deriv
prepar
cleav
clai
restrict
enzym
use
templat
vitro
transcript
describ
previous
vitrotranscrib
rna
electropor
bhk
cell
express
homolog
fecv
n
protein
bhktetonfecvn
h
incub
supernat
electropor
cell
harvest
upon
infect
felin
cell
supernat
cytopath
effect
cpe
develop
ident
confirm
sequenc
analysi
rtpcr
product
gener
viral
rna
infect
feli
catu
wholefetu
fcwf
cell
recombin
viru
display
growth
characterist
similar
display
serotyp
ii
fcov
strain
reach
peak
titer
pfuml
h
postinfect
pi
fig
plaqu
morpholog
recombin
viru
indistinguish
serotyp
ii
fcov
strain
fcwf
cell
data
shown
take
result
togeth
abl
gener
fcov
clone
contain
serotyp
ii
fcov
gene
sequenc
genom
background
serotyp
fecv
field
isol
cdna
success
recoveri
vitro
cultiv
recombin
virus
felin
cell
led
us
conclud
serotyp
fecv
field
isolatederiv
viru
backbon
fulli
function
enabl
effici
viru
replic
viru
contain
protein
establish
laboratori
strain
ultim
goal
gener
recoveri
recombin
serotyp
fecv
without
heterolog
sequenc
accordingli
experi
perform
chimer
viru
describ
intermedi
step
gener
recombin
serotyp
fecv
field
viru
authent
fecv
gene
serotyp
ii
sequenc
replac
appropri
gene
fecv
field
isol
result
vrecfecv
fig
recoveri
recombin
virus
fulllength
fecv
cdna
perform
describ
sinc
serotyp
fecv
propag
vitro
expect
recombin
virus
would
abl
grow
cell
cultur
therefor
surpris
inocul
fcwf
cell
supernat
electropor
cell
lead
cpe
moreov
fecvspecif
antigen
could
detect
monoclon
antibodi
antim
immunofluoresc
address
issu
whether
fecv
particl
releas
electropor
cell
cell
cultur
supernat
subject
ultracentrifug
step
pellet
obtain
use
analys
includ
electron
microscopi
ii
western
blot
iii
rtpcr
shown
fig
transmiss
electron
microscopi
studi
reveal
supernat
electropor
cell
viru
particl
coronaviruslik
morpholog
featur
includ
typic
spike
structur
present
look
indistinguish
particl
verifi
recfcov
particl
contain
cov
structur
protein
perform
western
blot
analysi
use
proteinspecif
monoclon
antibodi
shown
fig
promin
band
correspond
fecv
structur
protein
could
detect
corrobor
releas
recfcov
particl
transfect
cell
next
incorpor
viral
genom
rna
particl
assess
use
capsid
protect
assay
describ
previous
purpos
purifi
particl
subject
rnase
treatment
remov
free
viral
rna
prior
rna
extract
viru
particl
presenc
viral
genom
rna
particl
confirm
rtpcr
experi
provid
convinc
evid
recombin
serotyp
fecv
recov
fulllength
cdna
clone
gener
current
studi
indic
titer
viru
could
determin
plaqu
assay
therefor
decid
use
western
blot
analysi
estim
amount
protein
present
purifi
recfecv
particl
refer
use
protein
content
control
viru
known
produc
infecti
viru
progeni
follow
electropor
viral
genom
rna
titrat
viru
plaqu
assay
follow
electropor
vitrotranscrib
fulllength
genom
rna
recfecv
respect
parallel
experi
cell
cultur
supernat
electropor
cell
collect
subject
two
round
ultracentrifug
pellet
fraction
resuspend
ident
volum
nte
buffer
equal
amount
purifi
recfecv
stock
along
dilut
prepar
stock
subject
western
blot
analysi
use
proteinspecif
monoclon
antibodi
compar
amount
protein
present
viral
rescu
experi
perform
recfecv
respect
fig
quantif
protein
signal
respect
dilut
undilut
fraction
reveal
similar
amount
protein
recfecv
fig
basi
comparison
protein
content
titer
determin
use
viru
plaqu
assay
fcwf
cell
pfuml
conclud
recfecv
also
contain
viru
particlesml
support
conclus
also
determin
genom
copi
number
fraction
stock
dilut
recfecv
quantit
rtpcr
qrtpcr
remov
possibl
rna
molecul
outsid
particl
capsid
protect
assay
experi
reveal
similar
genom
rna
amount
recfecv
undilut
dilut
materi
fig
taken
togeth
data
provid
conclus
evid
recombin
serotyp
fecv
could
recov
cdna
clone
gener
studi
viru
particl
serotyp
ii
spike
enabl
effici
infect
cat
cell
authent
fecv
spike
allow
viru
grow
spread
cell
monolay
vitro
lack
cpe
develop
fecvspecif
antigen
fcwf
cell
inocul
recfecvcontain
cell
cultur
supernat
suggest
vitro
propag
recfecv
critic
depend
particular
gene
use
construct
viru
rather
viral
gene
furthermor
spite
inabl
passag
recfecv
vitro
show
similarli
larg
amount
recfecv
virion
could
recov
cell
passag
without
amplif
viral
passag
permiss
cell
follow
success
recoveri
recombin
virus
use
assess
abil
establish
infect
natur
host
fcov
serotyp
ii
strain
spike
report
effici
infect
cat
irrespect
viru
backbon
accordingli
use
control
four
seroneg
specificpathogenfre
spf
cat
infect
pfu
recfecv
cat
cat
number
virion
use
cat
infect
experi
determin
plaqu
assay
estim
recfecv
describ
avoid
crosscontamin
two
group
hous
separ
previous
oronas
intraperiton
ip
infect
rout
gener
use
experiment
infect
cat
fcov
mimic
natur
rout
fcov
infect
one
anim
group
cat
receiv
viru
inoculum
oronas
remain
two
cat
cat
inocul
intraperiton
anim
monitor
clinic
sign
daili
basi
period
week
assess
viru
shed
fecal
swab
sampl
collect
cat
daili
basi
analyz
nest
revers
transcriptionpcr
rtpcr
furthermor
blood
sampl
collect
weekli
monitor
fcovspecif
antibodi
respons
serum
sampl
cours
experi
infect
four
cat
develop
slight
fever
disappear
day
postinfect
pi
remain
week
notabl
clinic
symptom
could
observ
four
cat
fcovspecif
viral
rna
detect
fecal
swab
sampl
cat
infect
intraperiton
cat
earli
day
pi
fcovspecif
viral
rna
detect
day
later
anim
inocul
via
oronas
rout
cat
fecal
swab
sampl
cat
infect
recfecv
cat
remain
posit
entir
period
except
day
fig
contrast
fecal
swab
sampl
cat
infect
cat
remain
fcov
posit
week
later
fecal
sampl
cat
found
posit
sporad
end
studi
fig
rule
possibl
neg
result
due
detect
limit
nest
rtpcr
use
studi
subsequ
use
qrtpcr
assay
reevalu
total
fecal
sampl
samplesweekcat
collect
cat
two
sampl
collect
cat
week
pi
test
posit
nest
rtpcr
also
test
posit
use
qrtpcr
assay
swab
obtain
cat
found
contain
genom
copi
respect
swab
obtain
cat
contain
genom
copi
similarli
sampl
collect
cat
week
pi
test
posit
nest
rtpcr
test
posit
qrtpcr
genom
copi
cat
respect
remain
sampl
collect
cat
respect
test
neg
nest
rtpcr
week
remain
also
neg
qrtpcr
assay
data
indic
analys
result
two
assay
nest
rtpcr
qrtpcr
led
conclus
addit
measur
fcovspecif
antibodi
titer
serum
sampl
end
point
dilut
use
immunofluoresc
fcovinfect
crandel
rees
felin
kidney
crfk
cell
fig
titer
recfecv
determin
use
type
fcovinfect
crfk
cell
wherea
titer
measur
use
type
ii
fcovinfect
cell
upon
infect
recfecv
cat
serum
antibodi
peak
titer
develop
lower
titer
observ
cat
infect
cat
cat
inocul
intraperiton
cat
serum
antibodi
develop
faster
reach
peak
titer
earlier
intraperiton
infect
cat
serum
antibodi
reach
peak
titer
week
pi
week
declin
serum
antibodi
titer
determin
cat
infect
oronas
viru
reach
similar
peak
titer
week
pi
serum
antibodi
respons
found
similar
two
cat
infect
recfecv
cat
slightli
higher
titer
regularli
observ
cat
infect
via
intraperiton
rout
serum
antibodi
reach
peak
titer
cat
peak
titer
measur
cat
increas
record
week
pi
data
show
recfecv
caus
product
infect
cat
note
authent
recombin
serotyp
fecv
recov
fulllength
cdna
clone
induc
symptomless
persist
infect
cat
similar
seen
cat
particular
viru
origin
furthermor
experi
reveal
regardless
rout
infect
recombin
fecv
caus
persist
infect
gut
judg
continu
viru
shed
fece
verifi
infect
cat
recfecv
reproduc
induc
harmless
persist
infect
two
addit
cat
infect
oronas
separ
experi
viru
shed
antibodi
respons
cat
monitor
week
previous
describ
similarli
first
experi
viral
rna
detect
day
pi
furthermor
fecal
swab
sampl
collect
daili
basi
test
posit
throughout
cours
infect
fig
antibodi
titer
determin
cat
fig
similar
one
observ
earlier
cat
taken
togeth
data
confirm
conclus
recfecv
reproduc
caus
harmless
persist
infect
cat
infect
via
natur
rout
conclud
anim
experi
perform
addit
studi
use
postmortem
sampl
obtain
cat
infect
oronas
recfecv
analyz
viru
spread
vivo
determin
site
viral
replic
cat
euthan
rang
organ
includ
lung
liver
kidney
spleen
abdomin
lymph
node
sampl
well
gut
section
collect
use
subsequ
analys
use
nest
rtpcr
fcovspecif
rna
could
detect
colon
sampl
clarifi
whether
neg
result
due
detect
limit
nest
rtpcr
reinvestig
organ
sampl
qrtpcr
assay
obtain
result
complet
agreement
outcom
nest
rtpcr
assay
fcov
rna
exclus
detect
colon
sampl
genom
copiesg
tissu
consist
immunohistochemistri
ihc
studi
reveal
fcovspecif
antigen
could
detect
sampl
origin
colon
fig
data
agreement
local
fecv
nucleic
acid
protein
report
natur
occur
persist
fecv
infect
corrobor
conclus
recfecv
gener
studi
abl
establish
persist
infect
similar
caus
fecv
field
final
determin
fulllength
fecv
genom
sequenc
origin
cat
fecal
sampl
collect
right
cat
euthan
use
amplif
set
overlap
pcr
product
cover
entir
fecv
genom
compar
fecv
sequenc
deriv
viral
rna
isol
fecal
sampl
nucleotid
differ
recfecv
input
viru
sequenc
identifi
tabl
notabl
six
nonsynonym
mutat
found
gene
two
gene
one
data
show
genom
sequenc
input
recfecv
bare
alter
week
day
chang
locat
gene
similar
result
also
obtain
anoth
studi
resequenc
fulllength
fcov
genom
sever
week
postinfect
desmaret
et
al
report
nonsynonym
mutat
fcov
genom
day
pi
mutat
locat
gene
replicas
gene
gene
cours
fcov
infect
gener
caus
mild
symptom
cat
viru
variant
may
emerg
fundament
differ
pathogen
potenti
parent
viru
biotyp
switch
fecv
fipv
ie
lethal
biotyp
fcov
estim
occur
approxim
persist
infect
cat
past
year
signific
effort
sever
laboratori
made
identifi
genet
chang
involv
fecvtofipv
biotyp
switch
inform
essenti
understand
molecular
basi
fip
pathogenesi
turn
may
help
develop
new
diagnost
tool
possibl
novel
therapeut
prophylact
strategi
combat
import
diseas
differ
genom
fecv
fipv
identifi
compar
sequenc
analys
fecv
fipv
assum
respons
biotyp
switch
although
describ
chang
correl
emerg
fipv
specif
contribut
singl
combin
amino
acid
substitut
viral
pathogenesi
diseas
progress
infect
cat
establish
suitabl
experiment
system
avail
time
recombin
virus
known
genom
sequenc
along
set
genet
engin
mutant
deriv
particular
parent
viru
gener
revers
genet
character
anim
experi
unfortun
fecv
field
isol
grow
cell
cultur
specif
fail
produc
infecti
viru
progeni
unless
adapt
vitro
growth
condit
serial
passag
known
result
mutat
differ
region
viral
genom
lack
suitabl
cell
cultur
system
also
pose
major
obstacl
develop
revers
genet
approach
virus
far
revers
genet
system
establish
field
virus
apart
sever
cell
cultureadapt
fcov
strain
howev
turn
unsuit
studi
molecular
pathogenesi
fip
major
hurdl
establish
revers
genet
system
fecv
field
isol
inabl
recov
infecti
recombin
virus
cdna
clone
therefor
consid
major
achiev
effici
fecv
rescu
system
could
develop
present
studi
follow
extens
procedur
perform
optim
previous
establish
vaccinia
virusbas
system
hightit
recfecv
viru
stock
produc
recombin
fecv
gener
use
twostep
strategi
first
sought
confirm
serotyp
fecvderiv
backbon
enabl
effici
viral
replic
combin
gene
serotyp
ii
fipv
strain
latter
use
particular
protein
previous
shown
support
viru
growth
cell
cultur
irrespect
fcov
backbon
use
result
chimer
viru
could
rescu
grown
high
titer
vitro
confirm
fecv
backbon
fulli
function
second
gener
recombin
vaccinia
viru
carri
fulllength
fecv
cdna
includ
authent
gene
next
bhk
cell
express
fecv
n
protein
electropor
recombin
fulllength
recfecv
rna
supernat
collect
cell
use
inocul
felin
cell
given
cell
permiss
type
field
fcov
surpris
neither
cpe
fecvspecif
antigen
could
detect
cat
cell
inocul
supernat
electropor
bhk
cell
howev
use
rang
method
abl
show
recfecv
releas
electropor
cell
releas
coronaviruslik
particl
demonstr
transmiss
electron
microscopi
ident
purifi
rnasetr
particl
corrobor
rtpcr
analysi
use
fecv
genom
rnaspecif
primer
western
blot
fcov
proteinspecif
monoclon
antibodi
protein
content
genom
rna
content
determin
recfecv
prepar
found
similar
fig
f
led
us
conclud
rescu
effici
similar
two
virus
data
also
support
idea
vitro
propag
recombin
fecv
exclus
depend
type
spike
protein
viru
particl
next
address
issu
whether
recfecv
induc
product
infect
natur
host
cat
infect
recfecv
use
equal
amount
viru
two
group
viru
appli
oronas
one
cat
intraperiton
ip
infect
recfecv
result
continu
viru
shed
entir
cours
experi
fecal
swab
sampl
obtain
daili
basi
sampl
found
fcov
posit
nest
rtpcr
cat
infect
oronas
intraperiton
respect
data
show
irrespect
infect
rout
recfecv
establish
persist
infect
gut
analysi
fcovspecif
antibodi
respons
reveal
recfecv
induc
rel
low
antibodi
titer
similar
previous
report
natur
infect
fecv
similar
result
observ
oronas
infect
two
addit
cat
cat
independ
experi
indic
recfecv
could
reproduc
induc
harmless
persist
infect
determin
major
site
recfecv
replic
vivo
cat
infect
oronas
cat
subject
postmortem
analysi
week
postinfect
among
larg
number
tissu
sampl
collect
colon
tissu
sampl
test
posit
fcov
protein
viral
genom
viral
rna
protein
could
detect
tissu
sampl
confirm
recfecv
establish
persist
infect
colon
observ
agreement
local
viru
report
natur
fecv
infect
final
determin
recfecv
sequenc
fecal
sampl
collect
right
cat
euthan
sequenc
analysi
reveal
major
nonsynonym
nucleotid
chang
map
gene
particularli
subunit
desmaret
et
al
found
nonsynonym
mutat
subunit
fcov
spike
day
pi
sinc
domain
known
major
antigen
determin
induct
adapt
immun
respons
conceiv
observ
chang
subunit
repres
immun
escap
variant
structur
model
produc
protein
homologyanalog
recognit
engin
v
phyre
recfecv
subunit
suggest
observ
amino
acid
substitut
domain
map
surfac
region
outsid
receptorbind
site
fig
local
amino
acid
substitut
surfac
subunit
includ
domain
strongli
suggest
chang
might
contribut
viral
escap
host
immun
system
rather
increasingadjust
affin
cellular
receptor
suggest
previou
studi
protein
taken
togeth
recfecv
sequenc
data
obtain
sampl
collect
late
stage
infect
provid
independ
evid
recfecv
produc
studi
adapt
specif
ecolog
nich
initi
isol
ie
felin
colon
thu
recfecv
expect
provid
excel
tool
futur
studi
biolog
properti
fecv
genet
chang
requir
gener
fipv
biotyp
contrast
data
obtain
recfecv
infect
lead
continu
viru
shed
sampl
test
posit
nest
rtpcr
sporad
fecal
swab
sampl
cat
infect
oronas
intraperiton
respect
data
gener
qrtpcr
confirm
result
interestingli
contrast
titer
obtain
fcov
high
serum
antibodi
titer
determin
cat
reflect
strong
immun
respons
like
due
system
infect
lack
clinic
symptom
cat
infect
indic
protein
alon
fipv
strain
lead
biotyp
switch
even
though
may
respons
transit
enter
system
infect
interestingli
time
necropsi
week
pi
none
organ
sampl
obtain
cat
infect
oronas
test
posit
fecv
pcr
ihc
therefor
tempt
specul
strong
immun
respons
elicit
infect
elimin
viru
effici
rescu
recfecv
abil
caus
persist
enter
infect
cat
repres
mileston
fcov
biolog
research
molecular
pathogenesi
fip
studi
direct
approach
use
recfecv
tool
role
fecvfipv
discriminatori
mutat
emerg
fipv
directli
evalu
exampl
previous
propos
discriminatori
mutat
protein
well
nonfunct
furin
cleavag
site
introduc
recfecv
gene
possibl
effect
pathogen
result
recombin
virus
analyz
vivo
also
use
technolog
establish
studi
fecvfipv
viru
pair
obtain
cat
suffer
fip
serv
basi
construct
set
chimer
serotyp
field
virus
identifi
gene
mutat
determin
fipv
biotyp
infecti
clone
fecv
correspond
fipv
produc
systemat
exchang
genom
segment
fecv
match
genom
segment
fipv
allow
map
genet
chang
requir
turn
fecv
biotyp
fipv
biotyp
obvious
protocol
develop
studi
may
also
use
develop
revers
genet
system
rna
virus
larg
genom
coronavirus
nidovirus
suitabl
cell
cultur
system
avail
feli
catu
wholefetu
cell
monkey
kidney
cell
purchas
american
type
cultur
collect
european
collect
cell
cultur
respect
cell
kind
gift
g
l
smith
imperi
colleg
london
unit
kingdom
bhkteton
cell
provid
n
tautz
univers
luebeck
germani
cell
line
use
studi
maintain
dulbecco
modifi
eagl
medium
dmem
supplement
fetal
calf
serum
fc
penicillin
uml
streptomycin
mgml
propag
titrat
cell
recombin
vaccinia
virus
propag
purifi
describ
previous
fecal
sampl
cat
natur
fecv
infect
collect
consensu
sequenc
fecv
genom
determin
sanger
sequenc
clone
overlap
cdna
fragment
gener
rtpcr
gener
recombin
vaccinia
viru
contain
fulllength
cdna
serotyp
fecv
field
isol
vrecfecv
previous
produc
vrecfcovii
strain
modifi
total
eight
round
vaccinia
virusmedi
homolog
recombin
perform
escherichia
coli
guanosinephosphoribosyltransferas
gpt
select
marker
use
exchang
serotyp
ii
fcov
strain
cdna
fecv
field
isol
fulllength
cdna
vaccinia
viru
backbon
select
recombin
vaccinia
virus
perform
describ
previous
two
round
select
appli
exchang
region
serotyp
ii
fcov
strain
correspond
part
serotyp
fecv
field
isol
result
first
construct
vaccinia
viru
region
replac
gpt
gene
plasmid
use
vaccinia
virusmedi
homolog
recombin
vrecfcovii
base
contain
sequenc
correspond
nucleotid
nt
serotyp
ii
fcov
strain
nt
vaccinia
viru
genom
downstream
fcov
cdna
upstream
downstream
gpt
gene
respect
recombin
gptcontain
vaccinia
viru
obtain
gptposit
select
use
vaccinia
virusmedi
homolog
recombin
perform
plasmid
gener
recombin
vaccinia
viru
contain
sequenc
serotyp
fecv
serotyp
ii
fcov
cdna
plasmid
base
pgemt
promega
contain
nt
serotyp
ii
fcov
strain
nt
vaccinia
viru
vector
sequenc
downstream
fcov
cdna
upstream
downstream
nt
serotyp
fecv
field
isol
genom
respect
order
gener
contain
accessori
gene
e
gene
gene
n
gene
accessori
gene
fecv
field
isol
gene
type
ii
fcov
strain
previous
gener
vaccinia
viru
use
vaccinia
virusmedi
recombin
plasmid
plasmid
contain
sequenc
correspond
nt
vaccinia
viru
genom
upstream
fcov
cdna
nt
type
ii
fcov
strain
genom
downstream
upstream
gpt
gene
respect
recombin
gptposit
vaccinia
viru
obtain
gptposit
select
use
vaccinia
virusmedi
recombin
plasmid
gener
recombin
vaccinia
viru
gptneg
select
plasmid
base
pgemt
contain
nt
vaccinia
viru
genom
upstream
fcov
cdna
nt
serotyp
fecv
genom
follow
nt
type
ii
fcov
strain
genom
gener
contain
gene
serotyp
ii
fcov
strain
serotyp
fecv
field
isol
cdna
use
vaccinia
virusmedi
homolog
recombin
plasmid
plasmid
contain
sequenc
correspond
nt
vaccinia
viru
genom
upstream
fcov
cdna
follow
nt
fecv
field
isol
genom
upstream
gpt
gene
nt
serotyp
fecv
field
isol
genom
downstream
gpt
gene
recombin
gptcontain
vaccinia
viru
obtain
gptposit
select
use
vaccinia
virusmedi
homolog
recombin
plasmid
gener
recombin
vaccinia
viru
gptneg
select
plasmid
base
pgemt
contain
nt
serotyp
fecv
field
isol
genom
order
gener
vrecfecv
contain
fulllength
serotyp
fecv
cdna
authent
gene
use
vaccinia
virusmedi
homolog
recombin
plasmid
plasmid
contain
sequenc
correspond
nt
nt
serotyp
fecv
field
isol
genom
upstream
downstream
gpt
gene
respect
recombin
gptcontain
vaccinia
viru
obtain
gptposit
select
use
vaccinia
virusmedi
homolog
recombin
plasmid
pfecv
gener
recombin
vaccinia
viru
vrecfecv
gptneg
select
plasmid
pfecv
base
pgemt
contain
nt
serotyp
fecv
field
isol
genom
recoveri
recombin
fcov
cell
line
express
n
protein
fecv
field
isol
gener
bhktetonnfecv
bhkteton
cell
kind
gift
n
tautz
univers
luebeck
germani
transfect
plasmid
encod
n
protein
serotyp
fecv
field
isol
singl
cell
coloni
collect
puromycin
select
express
fecv
field
isol
n
protein
determin
western
blot
h
addit
doxycyclin
cultur
medium
recov
recombin
fcov
dna
deriv
recombin
vaccinia
virus
extract
prepar
scale
cleav
clai
neb
use
templat
vitro
transcript
describ
previous
vitrotranscrib
rna
electropor
bhktetonnfecv
cell
supernat
electropor
cell
contain
recombin
fcov
harvest
h
incub
half
purifi
ultracentrifug
analys
case
vivo
experi
second
half
supernat
electropor
cell
use
infect
cat
see
ident
recombin
fcov
determin
sequenc
analysi
half
supernat
ml
electropor
cell
contain
recombin
fcov
centrifug
g
min
remov
cell
debri
recombin
fcov
purifi
two
round
ultracentrifug
viru
pellet
wtvol
sucros
cushion
rpm
h
rotor
resuspend
nte
buffer
nacl
tri
ph
edta
centrifug
second
time
wtvol
sucros
cushion
supplement
nte
buffer
rpm
h
rotor
obtain
highli
purifi
viru
particl
resuspend
nte
buffer
und
use
experi
fcov
particl
purifi
concentr
ultracentrifug
use
sucros
cushion
contain
wtvol
paraformaldehyd
preserv
virion
morpholog
materi
resuspend
pellet
mount
pioloform
plano
wetzlar
carbon
coat
glow
discharg
use
copperrhodium
grid
wash
distil
water
stain
use
wtvol
uranyl
acet
grid
examin
zeiss
em
transmiss
electron
microscop
kv
imag
taken
use
magnificationcalibr
sidemount
chargecoupleddevic
ccd
camera
megaview
ii
si
muenster
germani
instrument
magnif
sdspage
analysi
purifi
viru
stock
dilut
mix
protein
sampl
buffer
ultracentrifug
heat
min
load
tricinepolyacrylamid
gel
western
blot
analysi
protein
separ
sdspage
transfer
onto
nitrocellulos
membran
ge
healthcar
block
membran
wash
pbst
phosphatebuff
salin
tween
incub
primari
antibodi
monoclon
mous
antifcovm
kind
gift
hohdatsu
h
room
temperatur
wash
pbst
perform
membran
incub
horseradish
peroxidaseconjug
goat
antimous
antibodi
dianova
h
room
temperatur
bound
antibodi
visual
chemiluminesc
reagent
western
lightn
plusecl
perkinelm
intens
band
correspond
protein
quantifi
use
chemidoc
imag
system
imag
lab
softwar
biorad
detect
genom
rna
purifi
recombin
viru
particl
capsid
protect
assay
perform
briefli
purifi
viru
stock
dilut
digest
ng
rnase
sigmaaldrich
min
reaction
mixtur
supplement
u
rnase
inhibitor
rnaseout
invitrogen
subject
rna
extract
follow
qrtpcr
analysi
rna
extract
fecal
swab
sampl
qiaamp
viral
rna
minikit
tissu
sampl
rneasi
minikit
qiagen
altern
rna
observ
capsid
protect
assay
use
qrtpcr
detect
viral
genom
rna
primer
design
base
determin
fecv
sequenc
pcr
mixtur
use
per
reaction
contain
taqman
fast
viru
master
mix
life
technolog
inc
forward
primer
agcgttgtactaagagcgttatgga
stock
solut
revers
primer
cacatcgaccttccttatacaaaaag
stock
solut
stock
solut
probe
fam
nucleasefre
water
sampl
rna
dilut
standard
rna
revers
transcript
step
min
enzym
activ
step
follow
cycl
steponeplu
realtim
pcr
system
thermocycl
appli
biosystem
vrecfecv
dna
use
templat
amplifi
pcr
product
cover
part
sequenc
use
forward
primer
contain
promot
sequenc
terminu
actgtaatacgactcactatagggctcgactagaaccctgtaatggt
revers
primer
acaatagcatcacaaaacgctacac
pcr
product
gel
purifi
vitro
transcrib
ribomax
rna
product
promega
afterward
vitrotranscrib
rna
treat
dnase
purifi
use
rneasi
minikit
qiagen
rna
concentr
determin
nanovu
ge
healthcar
tenfold
serial
dilut
rna
made
rang
log
unit
gener
standard
curv
effici
anim
experi
done
accord
guidelin
hungarian
legisl
anim
protect
protocol
approv
pest
megyei
kormanyhivat
budapest
assur
number
infect
anim
recombin
fcov
four
specificpathogenfre
spf
cat
use
age
month
first
experi
two
cat
second
experi
upon
arriv
kitten
test
fcov
seroneg
held
fcovfre
environ
week
prior
infect
time
fecal
serum
sampl
analyz
ensur
cat
expos
fcov
group
two
kitten
kept
togeth
durat
experi
week
strictli
separ
room
one
anim
group
inocul
intraperiton
wherea
cat
infect
oronas
supernat
electropor
cell
pfu
ml
first
experi
experi
follow
two
cat
infect
oronas
fecal
swab
sampl
collect
daili
basi
blood
sampl
weekli
basi
monitor
fecal
viru
shed
swab
sampl
subject
rna
extract
follow
nest
rtpcr
describ
previous
qrtpcr
determin
serum
antibodi
titer
indirect
immunofluoresc
assay
perform
briefli
crfk
cell
infect
typei
fcov
strain
black
typeii
fcov
strain
fix
serum
sampl
ad
dilut
start
infect
noninfect
cell
incub
bind
primari
antibodi
could
detect
use
anticat
conjug
goat
anticat
dianova
week
cat
infect
oronas
recfecv
euthan
tissu
sampl
well
fecal
sampl
gut
collect
fecal
sampl
use
determin
fulllength
genom
sequenc
fecv
genom
rna
extract
overlap
pcr
product
size
kb
amplifi
via
rtpcr
nextgener
sequenc
ng
rtpcr
product
perform
amplicon
sequenc
use
miseq
platform
reagent
kit
cycl
cdna
librari
sequenc
prepar
illumina
nextera
xt
dna
librari
prepar
kit
tissu
sampl
subject
rna
extract
follow
nest
rtpcr
qrtpcr
well
immunohistochemistri
identifi
site
fecv
replic
coronaviru
antigen
detect
immunohistochemistri
appli
standard
stain
protocol
use
primari
antibodi
monoclon
mous
antifcovm
kind
gift
hohdatsu
pretreat
target
retriev
agil
technolog
hamburg
germani
ph
secondari
antibodi
rat
antimous
igg
dianova
hamburg
germani
peroxidasebas
detect
system
dianova
hamburg
germani
reaction
visual
ad
chromogen
carl
roth
gmbh
co
kg
karlsruh
germani
control
consist
either
lymph
node
fipvinfect
cat
posit
control
control
creat
replac
primari
antibodi
monoclon
antibodi
direct
chicken
lymphocyt
neg
control
fulllength
genom
sequenc
determin
work
deposit
genbank
access
